(R)-α-(2-chloroethyl)-3-thiophenemethanol | 357405-59-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 杂芳族化合物
• 英文名称: (R)-α-(2-chloroethyl)-3-thiophenemethanol
• 英文别名: (R)-alpha-(2-Chloroethyl)-3-thiophenemethanol；(1R)-3-chloro-1-thiophen-3-ylpropan-1-ol
• CAS: 357405-59-5
• 化学式: C₇H₉ClOS
• 分子量: 176.667
• InChiKey: XVIGTAZXWNVUFN-SSDOTTSWSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  10
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  48.5
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  (R)-α-(2-chloroethyl)-3-thiophenemethanol 、 4-氯-2,5-二氟苯腈 生成 4-Chloro-2-[[(1R)-3-chloro-1-(3-thienyl)-propyl]oxy]-5-fluoro-benzonitrile
  参考文献：
  名称：

  Use of phenylheteroakylamine derivatives

  摘要：

  本发明揭示了使用化合物(I)的方法，其中R1、R2、X、Y、V、W和Z在说明书中有定义，并且其药学上可接受的盐、对映体或外消旋体，用于制造药物，用于治疗或预防抑制一氧化氮合酶活性对疾病或情况有益的疾病或情况。本发明揭示了某些新型化合物(Ia)及其药学上可接受的盐、对映体和外消旋体，以及它们的制备方法、含有它们的组合物以及它们在治疗中的应用。化合物(I)和(Ia)是一氧化氮合酶酶的抑制剂，因此在治疗或预防炎症性疾病方面特别有用。

  公开号：

  US06887871B2

文献信息

• Novel use of phenylheteroakylamine derivatives
  申请人：——

  公开号：US20030158185A1

  公开（公告）日：2003-08-21

  There is disclosed the use of a compound of formula (I) wherein R 1 , R 2 , X, Y, V, W and Z are as defined in the specification, and pharmaceutically acceptable salts, enantiomers or racemates thereof, in the manufacture of a medicament, for the treatment or prophylaxis of diseases or conditions in which inhibition of nitric oxide synthase activity is beneficial. Certain novel compounds of formula (Ia) and pharmaceutically acceptable salts thereof, and enantiomers and racemates thereof are disclosed; together with processes for their preparation, compositions containing them and their use in therapy. The compounds of formulae (I) and (Ia) are inhibitors of the enzyme nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory disease.

  公开了使用式（I）的化合物，其中R1、R2、X、Y、V、W和Z如规范中定义，并且其药学上可接受的盐、对映体或消旋体，在制备药物时用于治疗或预防抑制一氧化氮合酶活性有益的疾病或症状。公开了式（Ia）的某些新化合物及其药学上可接受的盐，以及其对映体和消旋体；以及它们的制备方法、含有它们的组合物以及它们在治疗中的应用。式（I）和（Ia）的化合物是一氧化氮合酶酶的抑制剂，因此在治疗或预防炎症性疾病方面特别有用。
• QUINOLINE AND ISOQUINOLINE DERIVATIVES FOR TREATING PAIN AND PAIN RELATED CONDITIONS
  申请人：Laboratorios del Dr. Esteve, S.A.

  公开号：EP3339304A1

  公开（公告）日：2018-06-27

  The present invention relates to new compounds of formula (I): showing great affinity and activity towards the subunit α2δ of voltage-gated calcium channels (VGCC), especially the α2δ-1 subunit of voltage-gated calcium channels or dual activity towards subunit α2δ of voltage-gated calcium channels (VGCC), especially the α2δ-1 subunit of voltage-gated calcium channels, and the noradrenaline transporter (NET).

  本发明涉及公式（I）的新化合物：对电压门控钙通道（VGCC）的亚单位α2δ具有很高的亲和力和活性，特别是对电压门控钙通道的α2δ-1亚单位或对电压门控钙通道的亚单位α2δ（VGCC）具有双重活性，特别是对电压门控钙通道的α2δ-1亚单位，以及去甲肾上腺素转运体（NET）。
• 3-ARYLOXY-3-ARYL-PROPYLAMINE COMPOUND AND USES THEREOF
  申请人：Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd

  公开号：EP3838900A1

  公开（公告）日：2021-06-23

  A 3-aryloxy-3-aryl-propylamine compound or a pharmaceutically acceptable salt of same, or a prodrug of same, and uses thereof. The compound has the structure of formula I. The compound, the pharmaceutically acceptable salt of same, or the prodrug of same provides an inhibitory effect with respect to a transient receptor potential (TRP) channel protein, and provides great therapeutic effects with respect to diseases related to the transient receptor potential channel protein.

  一种 3-芳氧基-3-芳基-丙胺化合物或其药学上可接受的盐或其原药及其用途。该化合物具有式 I 的结构。该化合物、其药学上可接受的盐或其原药对瞬时受体电位（TRP）通道蛋白有抑制作用，对与瞬时受体电位通道蛋白有关的疾病有很好的治疗效果。
• PREPARATION METHOD FOR AND CRYSTAL FORM OF 3-ARYLOXY-3-FIVE-MEMBERED HETEROARYL-PROPYLAMINE COMPOUND
  申请人：Zhangzhou Pien Tze Huang Pharmaceutical Co., Ltd.

  公开号：EP4105212A1

  公开（公告）日：2022-12-21

  Provided are a compound as represented by formula I, a preparation method therefor, and a hydrochloride crystal form A thereof. The compound as represented by formula I and the hydrochloride crystal form A thereof have excellent inhibitory effects on transient receptor potential (TRP) channels, and have good therapeutic effects on TRP channel-associated diseases.

  本发明提供了一种式 I 所代表的化合物、其制备方法及其盐酸盐晶型 A。式 I 所代表的化合物及其盐酸盐晶体 A 对瞬时受体电位（TRP）通道具有极佳的抑制作用，对 TRP 通道相关疾病具有良好的治疗效果。
• Quinoline and isoquinoline derivatives for treating pain and pain related conditions
  申请人：ESTEVE PHARMACEUTICALS, S.A.

  公开号：US10941138B2

  公开（公告）日：2021-03-09

  The present invention relates to new compounds of formula (I): showing great affinity and activity towards the subunit α2δ of voltage-gated calcium channels (VGCC), especially the α2δ-1 subunit of voltage-gated calcium channels or dual activity towards subunit α2δ of voltage-gated calcium channels (VGCC), especially the α2δ-1 subunit of voltage-gated calcium channels, and the noradrenaline transporter (NET).

  本发明涉及新的式（I）化合物： 对电压门控钙通道（VGCC）的α2δ亚基，特别是电压门控钙通道的α2δ-1亚基表现出极大的亲和力和活性，或对电压门控钙通道（VGCC）的α2δ亚基，特别是电压门控钙通道的α2δ-1亚基和去甲肾上腺素转运体（NET）表现出双重活性。